After FDA warning, Getinge trims sales of heart devices

After the FDA instructed healthcare facilities to avoid using two Getinge heart devices because of quality and safety concerns, the company stopped promoting the products. 

In a May 14 news release, the medical device company said it will "immediately pause promotional activities of the Cardiohelp System and Cardiosave [Intra-Aortic Balloon Pump] in the U.S. until outstanding actions related to quality improvements have been addressed and approved."

The decision is a response to the FDA's May 8 letter to providers, which said the agency has received 48 reports of deaths and serious injuries connected to Getinge balloon pumps, HLS sets and Cardiohelp systems. After numerous recalls and corrections, the FDA said it is still receiving reports of device issues. 

As Getinge works with the FDA, the company will limit sales of these hardware products to customers who do not have alternatives. 

Getinge's market share for the affected products is more than 60%, according to the release.

Subscribe to the following topics: fdaqualityhealthcare facilities

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy
.
 

Articles We Think You'll Like

Thank you so much for your interest in our content. Please register to access this complimentary archived content. By registering, you will receive our newsletter which can be opted out of at any time.

 

 

Already Registered? Click here to confirm.